An Open-Label Study of Aripiprazole in Children with a Bipolar Disorder

Abstract

The purpose of this open-label study was to describe the effectiveness of aripiprazole (APZ) in the treatment of children with bipolar disorders suffering from manic symptomatology

    Similar works